Gunderson Dettmer Reps Hearing Loss Co. On $105M Funding
A Gunderson Dettmer-advised life sciences company focused on developing gene therapies to help those with hearing problems said Tuesday it has closed on a $105 million financing round with help from numerous investors,...To view the full article, register now.
Already a subscriber? Click here to view full article